These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2276375)

  • 41. [Neurotoxicity in sodium azide poisoning].
    Fujimura T; Kobayashi H; Suzuki T; Sato I; Hara S
    Chudoku Kenkyu; 2002 Jul; 15(3):281-8. PubMed ID: 12415870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxicological and pharmacological effects of D-arginine.
    Navarro E; Alonso SJ; Martín FA; Castellano MA
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):149-54. PubMed ID: 16128908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the central antiserotonin action of trazodone.
    Baran L; Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1979; 31(1):25-33. PubMed ID: 482164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal experiments on the safety pharmacology of lofexidine.
    Graf E; Sieck A; Wenzl H; Winkelmann J
    Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. General pharmacology of the putative cognition enhancer linopirdine.
    Flagmeyer I; Gebert I; van der Staay FJ
    Arzneimittelforschung; 1995 Apr; 45(4):456-9. PubMed ID: 7779141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of alaphen on some functions of central nervous system].
    Masiuta GF
    Farmakol Toksikol; 1966; 29(5):524-7. PubMed ID: 5995061
    [No Abstract]   [Full Text] [Related]  

  • 48. [Neuropharmacological activity of 2 newly synthesized compounds from the piperazine group. I. The effect on experimental models of excitation and inhibition of the central nervous system].
    Ianeva-Balabanska I; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1986; 25(3):15-9. PubMed ID: 3757874
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuropharmacological studies on Fusarium toxins--I: Total toxin extract from Fusarium moniliforme.
    Ganguli S; Hota D; Goel RK; Acharya SB; Bhattacharya SK
    Indian J Exp Biol; 1996 May; 34(5):408-17. PubMed ID: 9063073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary pharmacological evaluation of chelidonine in rodents.
    Jagiełło-Wójtowicz E; Jusiak L; Szponar J; Kleinrok Z
    Pol J Pharmacol Pharm; 1989; 41(2):125-31. PubMed ID: 2594578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of antidepressant activity of some indole alkylamines.
    Sing KP; Gautam SK
    Arzneimittelforschung; 1977; 27(10):2002-5. PubMed ID: 21669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical and pharmacological properties of new tetrahydropyrimido-[2,1-f]-purines.
    Pawłowski M; Drabczyńska A; Gorczyca M; Malec D; Modzelewski J
    Pharmazie; 1995 Jul; 50(7):453-5. PubMed ID: 7675886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of benzodiazepines on the central action of narcotic analgesics.
    Matla J; Langwiński R
    Pol J Pharmacol Pharm; 1982; 34(1-3):135-44. PubMed ID: 6132369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substituted ergolines: potential antipsychotics with unique profile. I. Psychopharmacological characterization.
    Groó D; Palosi A
    Pol J Pharmacol Pharm; 1988; 40(6):593-601. PubMed ID: 2908363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychopharmacological studies on (--)-nuciferine and its Hofmann degradation product atherosperminine.
    Bhattacharya SK; Bose R; Ghosh P; Tripathi VJ; Ray AB; Dasgupta B
    Psychopharmacology (Berl); 1978 Sep; 59(1):29-33. PubMed ID: 100809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino ]1,2-a] quinoline hydrochloride (compound 69/183). Part III: Assessment of tranquillising activity.
    Singh GB; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1978; 28(8):1403-6. PubMed ID: 37855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anorectic activity of some amphetamine-derivatives with low CNS stimulating potency.
    Gemignani A; Versace P; Cugurra F; Vaccari A
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):88-101. PubMed ID: 4643290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.